• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Why Roche's Acquisition Of Spark May Be Complete By Year's End

cafead

Administrator
Staff member
  • cafead   Oct 26, 2019 at 02:22: PM
via Roche's (RHHBY) acquisition of Spark Therapeutics (ONCE) will likely close before the year ends, an analyst said after reports suggested U.S. regulators would bless the deal.

article source